Global Insomnia Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global insomnia market in its upcoming report titled, “Global Insomnia Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global insomnia market is estimated to register a CAGR of X.X% in terms of value during the forecast period (2018–2027). The report offers in-depth insights, revenue details, and other vital information regarding the global insomnia, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global insomnia market report has been segmented on the basis of therapy type, drug formulation, diseases condition and region.

Request Covid - 19 Impact

Insomnia, commonly known as sleeplessness or sleep deprivation, is a disorder wherein an individual is either unable to sleep or sleeps only partially or without adequate sleep. Insomnia affects quality of life and thought process as you feel unwell mentally and physically. Insomnia can affect people of any age and gender; however, it is more common in adult females and seriousness may increase during pregnancy, baby blues, and menopause. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years). Treatment of insomnia is given on the basis of condition or severity of disease. Common symptoms include obesity, concentration problems, reduced reaction time, memory related problems, poor immune system, daytime sleepiness, mood swings, anxiety, depression, and irritability.

Some causes of insomnia disorder include to disruption in circadian rhythm, chronic pain, hyperthyroidism, psychological stress, etc. Moreover, excessive use of drugs, such as caffeine, alcohol, and nicotine could lead to insomnia. These causes are the driving factors for growth of the global insomnia market. Other factors include technological advancements, rising demand for over-the-counter sleep aids, stressful lifestyle, job with extended periods of night shifts, environmental noise, extreme hot or cold conditions, hormonal changes, increasing number of mental disorders, Alzheimer’s and Parkinson’s disease, and sleeping next to snoring partner.

However, lack of awareness and education, and challenges in providing low-cost drugs coupled with highly competitive market for drugs, patent expiration, side-effects of drugs are major factors hampering market growth. As awareness regarding this condition grows, major potential can be tapped from a large undiagnosed insomnia population pool over the forecast period.

North America market accounts for major share in the global insomnia market, and is expected to maintain its dominance throughout the forecast period owing to technological advancements and rise in demand for over-the-counter drugs, followed by the market in Europe. Developing countries in Asia Pacific hold profitable opportunities for new entrants and existing vendors to invest in the countries of Asia Pacific with the elevating per capita income and upsurge in occurrence of insomnia disorder.

Global Insomnia Market is segmented and further sub-segmented as follows:

Global insomnia market, by types of therapy:

• Pharmacological Therapy
• Benzodiazepines
• Non-benzodiazepines
• Melatonin receptor agonists
• Other
• Non-pharmacological therapy
• Relaxation therapy
• Cognitive behavioral therapy
• Sleep hygiene education
• Stimulus control
• Paradoxical intention
• Other

Global insomnia market, by drug formulation:

• Capsules
• Tablet
• Others

Global insomnia market, by disorder type:

• Poor quality of sleep
• Sleep maintenance
• Other

Global insomnia market, by region:

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

• Eisai Co.
• Pfizer Inc.
• Merck & Co. Inc.
• Sanofi Pasteur
• Takeda Pharmaceutical Company
• Meda Consumer Healthcare Inc.
• Pernix Therapeutics
• Purdue Pharma L.P.
• Consumer Healthcare Inc.
• Dainippon Sumitomo
• ECR Pharmaceuticals
• Flynn Pharma
• Johnson & Johnson
• Astellas
• Biocodex S A
• Neurim
• SkyePharma
• Vanda Pharmaceuticals Inc.